D-dimer level in COVID-19 infection: a systematic review

M Rostami, H Mansouritorghabeh - Expert review of hematology, 2020 - Taylor & Francis
Introduction COVID-19 disease has spread worldwide from December 2019 to the present
day; the early stage of this disease can be associated with high D-dimer, prolonged PT, and …

COVID-19 in immunocompromised hosts: what we know so far

M Fung, JM Babik - Clinical Infectious Diseases, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused significant morbidity and …

Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis

P Ssentongo, AE Ssentongo, ES Heilbrunn, DM Ba… - PloS one, 2020 - journals.plos.org
Background Estimating the risk of pre-existing comorbidities on coronavirus disease 2019
(COVID-19) mortality may promote the importance of targeting populations at risk to improve …

Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19

DL Jones, MQ Baluja, DW Graham, A Corbishley… - Science of the Total …, 2020 - Elsevier
The recent detection of SARS-CoV-2 RNA in feces has led to speculation that it can be
transmitted via the fecal-oral/ocular route. This review aims to critically evaluate the …

[HTML][HTML] COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients

JA Belsky, BP Tullius, MG Lamb, R Sayegh, JR Stanek… - Journal of Infection, 2021 - Elsevier
Background The clinical impact of severe coronavirus disease 2019 (COVID-19), caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in immunocompromised …

Clinical characteristics and outcomes of COVID-19–infected cancer patients: a systematic review and meta-analysis

H Zhang, H Han, T He, KE Labbe… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Previous studies have indicated coronavirus disease 2019 (COVID-19) patients
with cancer have a high fatality rate. Methods We conducted a systematic review of studies …

Infectious Diseases Society of America guidelines on the diagnosis of coronavirus disease 2019

KE Hanson, AM Caliendo, CA Arias… - Clinical infectious …, 2020 - academic.oup.com
IDSA Disclaimer As of the time of this publication, updates have been made to IDSA's
Guidelines on the Diagnosis of COVID-19. For the most updated version of these guidelines …

[HTML][HTML] COVID-19 in cancer patients: risk, clinical features, and management

C Liu, Y Zhao, D Okwan-Duodu, R Basho… - Cancer biology & …, 2020 - ncbi.nlm.nih.gov
A novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) has spread across the world, prompting the World Health Organization to declare the …

Factors associated with disease severity and mortality among patients with COVID-19: A systematic review and meta-analysis

V Chidambaram, NL Tun, WZ Haque, MG Majella… - PloS one, 2020 - journals.plos.org
Background Understanding the factors associated with disease severity and mortality in
Coronavirus disease (COVID-19) is imperative to effectively triage patients. We performed a …

Differences in outcomes and factors associated with mortality among patients with SARS-CoV-2 infection and cancer compared with those without cancer: a …

E Khoury, S Nevitt, WR Madsen, L Turtle… - JAMA network …, 2022 - jamanetwork.com
Importance SARS-CoV-2 infection has been associated with more severe disease and
death in patients with cancer. However, the implications of certain tumor types, treatments …